CVX Stock Analysis: Chevron | NYSE
Oil & Gas Integrated | NYSE, USA | Market Cap: 371.269m USD | 12M Return: 32.6% | US1667641005 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.46B
EPS Trend: -81.5%
Qual. Beats: 2
Rev. Trend: -32.2%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Chevron Corporation (NYSE: CVX) is a United States-based integrated energy and chemicals company that operates through three main segments: Upstream, Downstream, and All Other. The Upstream segment focuses on the exploration, development, production, and transportation of crude oil and natural gas, as well as LNG processing and emerging activities such as carbon capture and storage. The Downstream segment refines crude oil into petroleum products, manufactures renewable fuels, and produces commodity petrochemicals, plastics, and fuel and lubricant additives. The All Other segment handles cash management, debt financing, insurance, real estate, and technology activities. The company has a global operational footprint spanning North America, South America, Europe, Africa, Asia, and Australia.
Founded in 1879 and headquartered in Houston, Texas, Chevron was formerly known as ChevronTexaco Corporation before adopting its current name in May 2005. As a Mega Cap stock classified within the GICS Energy sector and the Integrated Oil & Gas sub-industry, Chevron is one of the largest publicly traded energy companies in the world. The integrated business model-spanning exploration and production alongside refining, marketing, and chemicals-allows the company to participate across multiple stages of the hydrocarbon value chain, which can help offset volatility in any single segment of the energy market.
- Crude oil price swings drive upstream revenue volatility
- Permian and Tengiz production growth expands output capacity
- Capital returns through dividends and buybacks remain elevated
| Net Income: 20.6b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 1.23 > 1.0 |
| NWC/Revenue: 6.24% < 20% (prev -0.07%; Δ 6.31% < -1%) |
| CFO/TA 0.14 > 3% & CFO 47.6b > Net Income 20.6b |
| Net Debt (34.8b) to EBITDA (55.8b): 0.62 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.98b) vs 12m ago 14.54% < -2% |
| Gross Margin: 31.00% > 18% (prev 28.77%; Δ 2.22% > 0.5%) |
| Asset Turnover: 71.85% > 50% (prev 74.85%; Δ -3.00% > 0%) |
| Interest Coverage Ratio: 22.46 > 6 (EBIT TTM 32.1b / Interest Expense TTM 1.43b) |
| A: 0.04 (Total Current Assets 49.4b - Total Current Liabilities 36.3b) / Total Assets 330b |
| B: 0.64 (Retained Earnings 210b / Total Assets 330b) |
| C: 0.11 (EBIT TTM 32.1b / Avg Total Assets 290b) |
| D: 1.41 (Book Value of Equity 190b / Total Liabilities 135b) |
| Altman-Z'' = 4.56 = AA |
| DSRI: 1.29 (Receivables 25.3b/17.7b, Revenue 209b/188b) |
| GMI: 0.93 (GM 28.77% / 31.00%) |
| AQI: 0.69 (AQ_t 0.19 / AQ_t-1 0.27) |
| SGI: 1.11 (Revenue 209b / 188b) |
| TATA: -0.08 (NI 20.6b - CFO 47.6b) / TA 330b) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of August 13, 2026, the stock is trading at USD 196.60 with a total of 4,357,319 shares traded. Over the past week, the price has changed by +5.47%, over one month by +7.90%, over three months by +6.70% and over the past year by +32.63%.
Current recommended Stop Loss: 190.00 (which is 3.4% or 1.4 ATR below the current price).
Chevron has received a consensus analysts rating of 3.88. Therefore, it is recommended to buy CVX.
- StrongBuy: 9
- Buy: 6
- Hold: 9
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 216.8 | 10.2% |
P/E Trailing = 17.9535
P/E Forward = 13.4953
P/S = 1.7733
P/B = 2.0645
P/EG = 0.7988
Revenue TTM = 209b USD
EBIT TTM = 32.1b USD
EBITDA TTM = 55.8b USD
Long Term Debt = 39.1b USD (from longTermDebt, last fiscal year)
Short Term Debt = 2.81b USD (from shortTermDebt, last fiscal year)
Debt = 43.4b USD (corrected: LT Debt 39.1b + ST Debt 2.81b) + Leases 1.45b
Net Debt = 34.8b USD (calculated: Debt 43.4b - CCE 8.53b)
Enterprise Value = 406b USD (371b + Debt 43.4b - CCE 8.53b)
Interest Coverage Ratio = 22.46 (Ebit TTM 32.1b / Interest Expense TTM 1.43b)
EV/FCF = 16.03x (Enterprise Value 406b / FCF TTM 25.3b)
FCF Yield = 6.24% (FCF TTM 25.3b / Enterprise Value 406b)
FCF Margin = 12.14% (FCF TTM 25.3b / Revenue TTM 209b)
Net Margin = 9.87% (Net Income TTM 20.6b / Revenue TTM 209b)
Gross Margin = 31.00% ((Revenue TTM 209b - Cost of Revenue TTM 144b) / Revenue TTM)
Gross Margin QoQ = 45.52% (prev 9.58%)
Tobins Q-Ratio = 1.23 (Enterprise Value 406b / Total Assets 330b)
Interest Expense / Debt = 3.29% (Interest Expense 1.43b / Debt 43.4b)
Taxrate = 31.58% (9.68b / 30.6b)
NOPAT = 21.9b (EBIT 32.1b * (1 - 31.58%))
Current Ratio = 1.36 (Total Current Assets 49.4b / Total Current Liabilities 36.3b)
Debt / Equity = 0.23 (Debt 43.4b / totalStockholderEquity, last quarter 190b)
Debt / EBITDA = 0.62 (Net Debt 34.8b / EBITDA 55.8b)
Debt / FCF = 1.38 (Net Debt 34.8b / FCF TTM 25.3b)
Total Stockholder Equity = 187b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.09% (Net Income 20.6b / Total Assets 330b)
RoE = 10.98% (Net Income TTM 20.6b / Total Stockholder Equity 187b)
RoCE = 14.15% (EBIT 32.1b / Capital Employed (Equity 187b + L.T.Debt 39.1b))
RoIC = 7.62% (NOPAT 21.9b / Invested Capital 288b)
WACC = 6.30% (E(371b)/V(415b) * Re(6.77%) + D(43.4b)/V(415b) * Rd(3.29%) * (1-Tc(0.32)))
Discount Rate = 6.77% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 64.60 | Cagr: 2.97%
[DCF] Terminal Value 77.97% ; FCFF base≈21.7b ; Y1≈24.8b ; Y5≈36.6b
[DCF] Fair Price = 262.6 (EV 550b - Net Debt 34.8b = Equity 515b / Shares 1.96b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -81.53 | EPS CAGR: -19.73% | SUE: 1.06 | # QB: 2
Revenue Correlation: -32.20 | Revenue CAGR: -1.29% | SUE: 3.29 | # QB: 1
EPS current Quarter (2026-09-30): EPS=4.52 | Chg30d=+6.40% | Revisions=-31% | Analysts=16
EPS current Year (2026-12-31): EPS=15.84 | Chg30d=+11.10% | Revisions=+11% | GrowthEPS=+117.3% | GrowthRev=+20.8%
EPS next Year (2027-12-31): EPS=12.93 | Chg30d=+2.34% | Revisions=-21% | GrowthEPS=-18.3% | GrowthRev=-8.5%
[Analyst] Revisions Ratio: -15% (up=19, down=26)